This will be too late for my dad, but it is very interesting way of treating glioma. I wish them every success with their trials.
UCSF News Office - UCSF launches new phase of brain tumor vaccine trial
UCSF News Office - UCSF launches new phase of brain tumor vaccine trial
The Brain Tumor Research Center at the University of California, San Francisco has initiated a Phase 2 clinical trial of an investigational vaccine for treating glioma, a recurrent cancer of the central nervous system that occurs primarily in the brain.
The primary objective of the new trial is to evaluate overall survival in patients receiving vitespen vaccination (trademarked as Oncophage).
In an earlier Phase 1 trial of the vaccine, UCSF researchers showed that it was effective in stimulating the patient’s immune system to attack tumor cells. Of the 12 patients treated, all showed an immune response.
